Abstract
It has been recently established that GPR158, a class C orphan G protein-coupled receptor, serves as a metabotropic glycine receptor. GPR158 is highly expressed in the nucleus accumbens (NAc), a major input structure of the basal ganglia that integrates information from cortical and subcortical structures to mediate goal-directed behaviors. However, whether glycine modulates neuronal activity in the NAc through GPR158 activation has not been investigated yet. Using whole-cell patch-clamp recordings, we found that glycine-dependent activation of GPR158 increased the firing rate of NAc medium spiny neurons (MSNs) while it failed to significantly affect the excitability of cholinergic interneurons (CIN). In MSNs GPR158 activation reduced the latency to fire, increased the action potential half-width, and reduced action potential afterhyperpolarization, effects that are all consistent with negative modulation of potassium M-currents, that in the central nervous system are mainly carried out by Kv7/KCNQ-channels. Indeed, we found that the GPR158-induced increase in MSN excitability was associated with decreased M-current amplitude, and selective pharmacological inhibition of the M-current mimicked and occluded the effects of GPR158 activation. In addition, when the protein kinase A (PKA) or extracellular signal-regulated kinase (ERK) signaling was pharmacologically blocked, modulation of MSN excitability by GPR158 activation was suppressed. Moreover, GPR158 activation increased the phosphorylation of ERK and Kv7.2 serine residues. Collectively, our findings suggest that GPR158/PKA/ERK signaling controls MSN excitability via Kv7.2 modulation. Glycine-dependent activation of GPR158 may significantly affect MSN firing in vivo, thus potentially mediating specific aspects of goal-induced behaviors.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Glycine acts as an inhibitory neurotransmitter in the spinal cord, brainstem, and cerebellum where it binds ionotropic glycinergic receptors that are permeable to chloride ions [1, 2]. Through these inhibitory receptors glycine participates in the control of fluxes of sensory information between the periphery and the CNS, as well as diverse motor activities like locomotion and respiration [3,4,5,6]. Glycine is also a co-agonist of N-methyl-d-aspartate glutamate receptors (NMDAR). Indeed, ion flux through these receptors depends on their interaction with both glutamate and glycine, the latter binding the GluN1 subunit [7].
Alongside activating ionotropic receptors, a recent seminal work has shown that glycine can also bind GPR158, an orphan Class C of G-protein-coupled receptor (GPCR) [8]. The discovery that GPR158 serves as a metabotropic glycine receptor (mGlyR) opened new perspectives on the understanding of the complexity of glycinergic transmission in the CNS, also considering that glycine and GPR158 have been implicated in a number of pathological conditions including depression [9,10,11,12,13,14].
GPR158 transduces signals by its interaction with the RGS7–Gβ5 complex, comprising the intracellular regulator of G-protein signaling 7 (RGS7) in complex with the G-protein beta-5 subunit (Gβ5) [8, 15,16,17]. Since RGS7-Gb5 is a selective guanosine triphosphatase (GTPase)-activating protein (GAP) for the inhibitory Gi/o proteins, which regulate cAMP production, inhibition of RGS7-Gb5 activity via GPR158 increases cAMP levels in neurons [8, 13]. Indeed, GPR158 activation produces an excitatory effect in many neuronal types by modulating key kinases, neurotrophic factors, and ion channels involved in neuronal excitability and synaptic transmission [14, 18,19,20].
GPR158 is highly expressed in brain regions implicated in the regulation of depression-related behaviors, such as the hippocampus, prefrontal cortex and nucleus accumbens (NAc) [14, 15, 21, 22]. However, little is known about neuronal adaptations following GPR158 activation in these brain areas, especially in the NAc, the main component of the ventral striatum that mediates goal-directed behaviors by integrating information from the neocortical, allocortical, thalamic, midbrain and brainstem structures [23, 24]. The major projection neurons that regulate goal-directed behaviors, the medium spiny neurons (MSNs; about 95% of total NAc neurons), are GABAergic neurons that can be distinguished in two subpopulations based on expression of dopamine receptors: D1R-MSNs expressing D1 receptors (D1R) and D2R-MSNs expressing D2 receptors (D2R) [25,26,27]. Alongside MSNs, cholinergic interneurons (CINs), comprising 1–3% of striatal neurons [28], are known to be critical for NAc functions [29, 30]. The high levels of GPR158 expression in the NAc and GPR158’s emerging role as an active modulator in physiological and pathological conditions prompted us to investigate the effects of GPR158 activation on intrinsic excitability of NAc MSNs and CINs. We found that GPR158 activation enhances intrinsic excitability in MSNs, but not in CINs, through PKA/ERK-dependent modulation of M-type potassium currents carried by Kv7 channels.
Materials and methods
Animals and ethical approval
We used male C57BL/6J mice. Colonies were established in the animal facilities at Università Cattolica del Sacro Cuore. The housing conditions were controlled, maintaining stable hygrometric and thermic conditions (50%; 21 °C ± 1 °C) on a 12-hour light/dark cycle with ad libitum access to food and water. Four- to six‐week‐old mice were used. All procedures complied with the Italian Ministry of Health (Law 116/92) and European Community Council (Directive 86/609/EEC) guidelines. This project has received approval from the Italian Ministry of Health (authorization n° 623/2022-PR).
Slice preparation and electrophysiology
Coronal slices (300 μm) containing the nucleus accumbens were prepared as previously described [31,32,33]. C57/BL/6J mice postnatal days (P) 28–42 were anesthetized with isoflurane and killed by cervical dislocation and decapitated. The brains were quickly removed and placed in an ice-cold, sucrose-based cutting solution containing the following (in mM): TRIS-HCl 72, TRIZMA base 18, NaH2PO4 1.2, NaHCO3 30, KCl 2.5, glucose 25, HEPES 20, MgSO4 10, Na-pyruvate 3, ascorbic acid 5, CaCl2 0.5, sucrose 20. NAc slices (300 μm thick) were cut on a vibratome (VT1200S; Leica Microsystems, Germany) and soon transferred to an incubation chamber held at 32 °C and filled with a recovery solution containing (in mM): TRIS-HCl 72, HEPES 20, NaH2PO4 1.2, TRIZMA base 18, KCl 2.5, NaHCO3 25, CaCl2 0.5, glucose 25, MgSO4 10, Na-pyruvate 3, ascorbic acid 5, sucrose 20. After 30 min, slices were transferred to a second incubation chamber held at 32 °C and filled with artificial cerebrospinal fluid (aCSF) containing the following (in mM): NaCl 124, KCl 3.2, NaH2PO4 1.2, MgCl2 1, CaCl2 2, NaHCO3 26, and glucose 10, pH 7.4. During incubations, the chambers were continuously bubbled with 95% O2/5% CO2. Finally, slices were equilibrated at RT for at least 30 min. For electrophysiological recordings, slices were transferred to a submerged recording chamber constantly perfused at 2 ml/min with heated aCSF in the presence of the following synaptic blockers: picrotoxin (100 mM), strychnine (1 mM), NBQX (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; 20 mM), and APV (D, L-2-amino-5-phosphonovaleric acid; 50 mM).
The MSNs of the NAc were visualized under DIC infrared illumination. Patch pipettes had a resistance of 4–6 MΩ when filled with an internal solution containing (in mM): K-gluconate 145, MgCl2 2, HEPES 10, EGTA 0.1, Na-ATP 2.5, Na-GTP 0.25, phosphocreatine 5, pH adjusted to 7.2 with KOH. NAc cholinergic interneurons were selected for recordings based on their characteristic somatodendritic morphology, and their identity was confirmed by their stereotyped responses to current injection such us depolarizing sag that developed during a hyperpolarizing step of current, a rebound depolarization observed after the end of a hyperpolarizing step, and long-lasting afterpolarizations after bursts of spikes [34]. Recordings were performed using a Multiclamp 700B/Digidata 1550 A system (Molecular Devices, USA) and digitized at a 10,000 Hz sampling frequency. All the electrophysiological recordings were analyzed using the Clampfit 10.9 software (Molecular Devices). Evoked firings were recorded in whole-cell, current-clamp mode. Only cells with a stable resting membrane potential negative to − 70 mV, overshooting action potentials (exceeding 70–80 mV threshold-to-peak), and an input resistance > 100 MΩ were included. Additionally, cells were rejected if there was a 20% change in the input resistance and resting membrane potential. The membrane input resistance was measured by a series of 600 ms hyperpolarizing current steps from − 50 to 0 pA, step 10 pA with 1 s interval.
To test the firing properties of MSNs during continuous depolarization, we exposed these cells to a series of 1 s of somatic current pulses (every 10 s). The minimal amplitudes needed to cause a steady firing of 4–8 action potentials were used to determine the current levels. Beginning with 80 pA, the injected current was gradually increased in 10–50 pA increments until these criteria were satisfied. Of note, during interpulse intervals, the membrane potentials were maintained at resting value (∼80 mV for MSNs and ∼60 mV for CINs) by injecting hyperpolarizing/depolarizing currents. All the electrophysiological parameters were analyzed in 30–60 s (pre) and 5–10 min (post) drug application.
Measurements of action potential half-width and all action potential properties were taken from waveform averages representing 1 s per condition. AHP voltages were measured individually from raw traces before averaging.
The Kv7 currents were recorded in voltage–clamp mode. Currents induced by voltage steps from − 10 to − 60 mV preceded by a 4 s prepulse to 0 mV. Membrane capacitances and series resistance (Rs) were compensated electronically. Before compensation, Rs ranged from 5 to 20 MΩ and were regularly corrected by 75 to 85%. Data obtained from a given cells were rejected if Rs were larger than 20 MΩ or changed by > 20% during the experiment. The current amplitude was measured between the peak and the end of the voltage step. Potentials were not corrected for the liquid junction potential. Analysis and curve fitting were conducted in Clampfit and SigmaPlot 14.0 (Systat Software Inc., San Jose, CA, USA). The peak conductance (Gp) was calculated as Gp = Ip/(Vc − Vrev), where Ip is the peak current, Vc is the command voltage and Vrev is the estimated reversal potential for K+ (− 95 mV). The Gp–V relationships were described by assuming a first-order Boltzmann function: Gp(V) = Gpmax1/(1 + exp ((Vc − V1/2)/k), where Gpmax is the maximal peak conductance, k is the slope factor and V1/2 is the activation midpoint voltage.
To investigate the effects of GPR158 activation, 1 mM of Glycine was used based on the assumption that this concentration ensures maximal receptor stimulation in ex vivo NAc slices as in a recent study by Laboute and colleagues [8].
XE991-sensitive currents were obtained by subtracting the traces in the presence of XE991 (20 µM; the selective blocker of Kv7 channels), from those obtained before drug administration (upper left trances). Current densities were obtained dividing Kv7/M current amplitude by membrane capacitance. Membrane capacitance was calculated using the equation: capacitance = membrane time constant/input resistance [35].
Multiplex RNAscope™ and immunofluorescence and confocal analysis
RNAscope™ (Advanced Cell Diagnostic, USA) was performed according to the manufacturer’s protocol as in Wang and colleagues [36]. Briefly, adult C57BL/6J mice were deeply anesthetized, and the brains were collected. Afterward, brains were overnight post-fixed in 4% PFA and then were cryoprotected in sucrose solution (30%). 15 μm coronal slices were sectioned using a cryostat and mounted on Superfrost Plus slides. Sections were dehydrated and post-fixated according to the protocol, then peroxidase was applied, and antigen retrieval was performed. The following RNA probes were used: Mm-Gpr158-C1 (#524,851); Mm-Drd1 (#461,901-C2) and Mm-Drd2 (#406,501-C3) respectively for Gpr158, D1R and D2R was applied on sections. Then the amplification cascade was performed as stated in the manufacturer’s protocol and detected by using TSA-Vivid™ fluorophores 570 and 520. Before RNAscope processing, sections were incubated with primary antibodies including rabbit anti-Kv7.2 antibody (1:200; cod. D9L5S; Cell signaling), goat anti-ChAT (1:200; Cod. #AB144P; Sigma- Aldrich), and rabbit anti-GRP158 (1:200; cod. #PA5-102092; Thermo Fischer Scientific) in 0.1 M PB. After the RNAscope protocol, sections were incubated for 1 h at RT with secondary antibodies including Alexa Fluor 647 donkey anti-rabbit IgG or Alexa Fluor 647 donkey anti-goat (1: 200; Molecular Probes). Sections were air-dried and coverslipped with GEL/MOUNT (Biomeda, Foster City, CA, USA). Sections were examined under a confocal laser-scanning microscope Nikon APM1 equipped with four laser lines: violet diode emitting at 405 nm (for DAPI), argon emitting at 488 nm, and helium/neon emitting at 543 nm and 633.
Quantitative analysis of Gpr158-mRNA, Kv7.2 protein, GPR158 protein, and Gpr158-mRNA/GPR158 protein co-localization was performed offline on confocal images acquired through the 20× objective at the 0.01 zoom factor. All double-labeled cells in four sections, regularly spaced throughout the caudo-rostral extent of the NAc, were counted. The Gpr158-mRNA, Kv7.2 protein, and GPR158 protein immunofluorescence (optical density O.D.) was performed by densitometric analyses. Specifically, GPR158-mRNA, Kv7.2 protein, and GPR158 protein-associated signals were quantified by manually outlining individual cells and measuring cell-associated fluorescence intensity with the ImageJ software (http://rsb.info.nih.gov/ij/). The F/A ratio defines the mean fluorescence of individual cells (F) normalized to the total cellular surface (A). Quantification was done on 50 cells per mice for MSNs and on 15 cells for CINs (n = 4 mice).
Cellular co-localizations between Gpr158-mRNA, and GPR158 protein on neurons were analyzed by counting and characterizing cell labeling off-line through the Nikon proprietary image analysis program. Two digital images of the same optical section (one for each laser channel, green/or blue and red) were acquired and digitally merged in a third image, which was used for cell counting. The features of immunolabeled cells were analyzed by zooming on the cells and by serially excluding each channel (green and red) to better appreciate the cellular morphology. Double and single immunolabeled cells were then digitally marked, and recorded, and the material stored in a data archive.
Western-blot assay
Western blot experiments were performed as previously described [37]. Briefly, tissues were lysed in ice-cold lysis buffer (NaCl 150 mM, Tris-HCl 50 mM pH 7.4, EDTA 2 mM) containing 1% Triton X-100, 0.1% SDS, 1 × protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO, USA), 1 mM sodiumorthovanadate (Sigma-Aldrich) and 1 mM sodium fluoride (Sigma-Aldrich). Lysates were incubated for 10 min on ice with occasional vortexing and spun down at 22,000 g at 4 °C. The supernatant was quantified for protein content (DC Protein Assay; Bio-Rad, Hercules, CA, USA). Equal amounts of protein were diluted in Laemli buffer, boiled, and resolved by SDS-PAGE. Primary antibodies for anti-ERK1/2 (WB 1:1000, monoclonal, rabbit cell signaling #9102S), anti-pERK1/2 (WB 1:1000, polyclonal, rabbit cell signaling #4370S), anti-Actine (WB 1:2000 mouse Sigma Aldrich A2228) were incubated overnight and revealed with HRP-conjugated secondary antibodies (Cell Signaling Technology). Expression was evaluated and documented by using UVItec Cambridge Alliance. The band of interest was normalized to the housekeeping (Actine) and expressed as fold change versus control. Images shown were cropped for presentation with no manipulations.
Immunoprecipitation
Evaluation of Kv7.2 total phosphorylation level was performed by immunoprecipitating the specific protein (Kv7.2) and analyzing the level of phosphorylation on serine residues (anti-phospho-serine Abcam 1:1000 ab9332) by western blot. The ratio of Kv7.2 and phospho-serine signals was used as index of Kv7.2 serine phosphorylation. Immunoprecipitation was performed using 2 µg of antibody for 200 µg of protein extract with the Ademtech´s Bio-Adembeads paramagnetic bead system. Negative controls were performed with the same amount of protein extract sample immunoprecipitated with the corresponding purified IgG (Santa Cruz). Total lysates were run in the WB as loading controls.
Droplet digital PCR analysis
Analysis by ddPCR on single MSN or CIN was performed as previously described [38]. Briefly, intracellular contents, drawn into the tip of the patch pipette by applying negative pressure, were then transferred to RNase/DNase-free tubes as described in Cadwell and colleagues [39] and processed as in previous works [38, 40]. Four microlitres preAmp (1:10 dilution) were used to perform ddPCR in duplicate with EVA green to obtain a total droplet number > 14 000. Data are quantified as copy number µl mRNA levels were normalized to housekeeping gene GAPDH. The data in Figs. 2M and N and 8M and N are represented as box plots showing the median, upper, and lower quartiles of the data and minimum and maximum values as whiskers. Primers for GAPDH were as in Aceto et al [38]. Primers are as follows: DRD1 5’-AGATCGGGCATTTGGAGAGAT-3’ and 5’-TGCTGCCTCTTCTTCTGAGACA-3’; DRD2 5’-TCTGGAGGTGGTGGGTGAGT-3’ and 5’-TGCTTGCTGTGCACATCATG-3’; GPR158 5’-CTGCCACCTTAACAACTCAGAGTGT-3’ and 5’-CTGATAGGCTCCAAGCACGAA-3’; ChAT 5’-AGCTTGAATGGAGCGAATCG-3’ and 5’-TCTCGGCCCACCACAAAC-3’.
Statistical analysis
Data are expressed as means ± SEM. Statistical significance was assessed with either Student’s t-test or one-factor ANOVA for multiple-group comparisons (with Bonferroni post hoc test). Statistical analysis was performed with the SYSTAT 10.2 software (Systat Software). Two-tailed, non-parametric statistical comparisons were performed using the Wilcoxon signed-rank (WSR) test for paired data or the Mann-Whitney U (MWU) test for unpaired data. The level of significance was set at 0.05. n = number of individual cell recorded, each cell from a new slice, and each experiment from ≥ 3 mice for all electrophysiology experiments with no more than three cells from one any animal per experiment.
Results
GPR158 activation enhances the evoked firing of medium spiny neurons through a PKA-dependent mechanism
We first sought to determine the effects of GPR158 activation on MSN excitability. To this aim, we performed whole-cell patch-clamp recordings of identified NAc MSNs in ex vivo brain slices during perfusion of glycine (1 mM), the newly discovered agonist of GPR158 [8]. MSNs, which represent > 95% of neurons in the NAc, were identified by their electrophysiological characteristics: ramp depolarization at subthreshold levels, regular AP firing when stimulated with over-threshold voltages, and hyperpolarized resting membrane potential [41, 42].
To test the firing properties of MSNs during long-lasting depolarization, we applied 1-s somatic current pulses whose levels were chosen, in each recorded MSN, to elicit a stable firing of 4–8 action potentials. Glycine was bath applied for 5–10 min (Fig. 1A) in the presence of picrotoxin (100 µM), strychnine (1 µM), NBQX (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; 20 µM), and APV (D, L-2-amino-5-phosphonovaleric acid; 50 µM) to block its action on ionotropic receptors. Under these experimental conditions, application of glycine significantly increased the evoked firing in NAc MSNs (number of APs: pre = 5.26 ± 0.41; post = 11.29 ± 1.24; n = 13 cells from 5 mice; P < 0.0001; paired Student’s t-test; Fig. 1B, C), an effect that was absent when ACSF (vehicle) was applied (number of APs: pre = 5.56 ± 0.62; post = 5.47 ± 0.76; n = 13 cells from 5 mice; P > 0.05; paired Student’s t-test; Supplementary Fig. 1A, B). Of note, glycine’s effect on evoked firing was independent of MSN localization in NAc core and shell (Supplementary Fig. 1C; NAc shell; number of APs: pre = 5.79 ± 0.63; post = 11.8 ± 1.5; n = 7 cells from 3 mice; P < 0.05; paired Student’s t-test; NAc core; number of APs: pre = 4.64 ± 0.48; post = 10.80 ± 2.31; n = 6 cells from 2 mice; P > 0.018; paired Student’s t-test). In a subset of experiments, we observed that twenty minutes of washout from glycine induced a significant reduction of the evoked firing toward the control values, although the MSNs retained some degree of hyperexcitability (number of APs: pre = 6.69 ± 0.93; post = 11.17 ± 1.3; wash = 8.67 ± 0.84; n = 6 cells from 2 mice; P < 0.05; paired Student’s t-test).
We then tested whether glycine application could also affect the evoked firing of cholinergic interneurons (CINs). NAc CINs were identified based on their very large somata [43] and their distinctive electrophysiological properties, which included: i) a depolarizing sag that developed during a hyperpolarizing step of current, ii) a rebound depolarization observed after the end of a hyperpolarizing step, and (iii) marked, long-lasting afterpolarizations after bursts of spikes [43,44,45]. Interestingly, glycine application did not produce any changes in the intrinsic excitability of CINs (Fig. 1D, E and Supplementary Fig. 1D; number of APs: pre = 6.51 ± 0.95; post = 5.79 ± 1.19; n = 8 cells from 3 mice; P > 0.05; paired Student’s t-test) suggesting that GPR158 may be differently expressed in MSNs and CINs.
To test this hypothesis, we first employed RNAscope fluorescent in situ hybridization (FISH) combined with immunofluorescence (IF) in fixed CNS tissue sections which allows reliable quantification of multiplexed transcript detection within single IF-labeled cells. Tissue sections containing the NAc were used for multiplexed hybridization using distinct mRNA probes for Gpr158, D1R, and D2R combined with IF for choline acetyltransferase (ChAT) to identify CINs. As shown in Fig. 2, Gpr158 mRNA expression levels were comparable in D1R and D2R MSNs (average optic densities: D1 = 4.73 ± 0.35; D2 = 3.98 ± 0.70; one-way ANOVA; F (2,9) = 2.58; P > 0.05; followed by Bonferroni post hoc test) suggesting that the GPR158 signaling pathway may affect intrinsic excitability in both types of MSNs. Interestingly, and in line with our electrophysiology findings, lower Gpr158 mRNA were found in CINs compared to MSNs (Fig. 2; Average optic density: CINs = 1.79 ± 0.19; one-way ANOVA; F(2,9) = 2.58; P < 0.05; followed by Bonferroni post hoc test). Accordingly, experiments in which the mRNA probes for Gpr158 were coupled with GPR158 antibody also showed lower levels of protein in CINs (Supplementary Fig. 2). To Gpr158 mRNA expression was further investigated is single MSNs and CINs by using a protocol that combines whole-cell patch-clamp recordings with high-quality single-cell RNA analysis by droplet digital PCR (single-cell qRT-ddPCR) [38, 40, 46]. We found that Gpr158 mRNA expression in single MSNs expressing either D1R or D2R MSNs was comparable, in line with the results of RNAscope experiments (Fig. 2N). The Gpr158 mRNA expression in CINs was lower though not significantly different from that of MSNs (Fig. 2M). Of note, these data indicated the total RNA levels contained in each cell and cell size of CINs, which are the biggest neurons in the neostriatum (even > 40 μm), is far greater than that of MSNs. As such, Gpr158 density in CINs is markedly lower than in MSNs. Finally, GPR158 protein levels in NAc tissues were also assessed by western blot analysis (Fig. 2O).
Collectively, these findings suggest that glycine elicits positive modulation of MSN excitability by activation of the GPR158-signaling pathway, an effect that was missing in CINs likely because of the lower receptor density.
It has been shown that inhibition of RGS7-Gb5 activity, via GPR158 activation, affects cAMP levels in neurons [8, 13]. Since the cAMP/protein kinase A (PKA) pathway is one of the prominent and well-characterized signaling pathways in MSNs affecting a variety of intracellular targets including ion channels that regulate MSN excitability [47,48,49], we hypothesized that PKA-mediated protein phosphorylation could be involved in GPR158-dependent increase in evoked firing we observed in MSNs. To test this hypothesis, we bath applied a cell-permeable peptide inhibitor of PKA, PKI 14–22 amide, myristoylated (PKI 1 µM), for at least 10 min before glycine application. In the presence of PKI, GPR158 activation failed to significantly affect MSN firing rates (Fig. 3; number of APs: pre = 6.54 ± 0.76; post = 7.47 ± 1.14; n = 12 cells from 5 mice; P > 0.05; paired Student’s t-test) indicating that positive modulation of MSN excitability by glycinergic transmission requires intact PKA signaling.
We next sought to identify the molecular downstream target of PKA underlying the MSN intrinsic excitability modulation we observed following GPR158 activation. We first analyzed MSN AP properties before and after glycine application. As shown in Fig. 4A, B, we observed a significant reduction in mAHP after glycine application (mAHP amplitude: pre = 7.01 ± 0.53 mV; post: 5.97 ± 0.49 mV; n = 13 cells from 5 mice; P < 0.05; paired Student’s t-test). GPR158 activation also significantly increased the AP half-width (Fig. 4C; AP half-width: pre = 1.67 ± 0.09 ms; post = 1.81 ± 0.10 ms; n = 13 cells from 5 mice; P < 0.05; paired Student’s t-test). Moreover, we observed a significant reduction in the first spike latency (pre = 445.5 ± 21.7 ms; post = 249.0 ± 22.8 ms; n = 13 cells from 5 mice; P < 0.001; paired Student’s t-test; Fig. 7D, E). GPR158-dependent activation of the PKA signaling pathway may elevate MSN excitability through its effects on multiple classes of ion channels. However, the above changes in AP properties are consistent with negative modulation of K+ conductances, such as the M-currents, that in the central nervous system are mainly carried out by Kv7/KCNQ channels.
The Kv7/KCNQ/M channels are a subfamily of voltage-gated K+ channels with five members, Kv7.1 to Kv7.5, encoded by KCNQ1–5 genes [50,51,52]. In the brain, Kv7/M channels are formed by heterotetramers of the different subunits with Kv7.2/7.3 being the most prevalent [53,54,55]. Kv7/KCNQ/M channels regulate neuronal excitability by controlling repetitive firing, and the suppression of spontaneous firings [50]. Consistently with our findings, it has been shown that Kv7/KCNQ/M channel downregulation influences the amplitude of mAHP and the duration of AP [56,57,58,59].
GPR158 stimulation increases evoked firing through reduced Kv7/M-mediated currents
Data shown so far suggest that negative modulation of Kv7/M channels may underlie GPR158-induced increase in evoked firing. To test this hypothesis, we performed a new set of experiments in which the effect of glycine on MSN-evoked firing was studied in the presence of the specific Kv7 channel blocker, XE991. We hypothesized that if the GPR158-dependent increase in evoked firing was due to reduced Kv7/M channel activity, the pharmacological blockade of these channels would attenuate the effect of glycine. We first examined the effects of the pharmacological Kv7/M current blockade on evoked firing. As shown in Fig. 5A, B, when 20 µM XE991 was applied, the firing was significantly increased (number of APs: pre = 5.44 ± 0.48; post = 10.01 ± 0.98; n = 12 cells from 5 mice; P < 0.001; paired Student’s t-test). Interestingly, the magnitude of the increased evoked firing by XE991 was similar to that observed when glycine was applied (Fig. 1B). Of note, XE991 also mimicked the glycine’s effects on first spike latency, mAHP and half-width (Supplementary Fig. 3; first spike latency: pre = 376.7 ± 43.0 ms; post = 189.1 ± 20.7 ms; n = 12 cells from 5 mice; P < 0.001; paired Student’s t-test; mAHP amplitude: pre = -7.98 ± 0.43 mV; post: -6.69 ± 0.28 mV; n = 12 cells from 5 mice; P < 0.05; paired Student’s t-test; AP half-width: pre = 1.37 ± 0.16 ms; post = 1.61 ± 0.24 ms; n = 12 cells from 5 mice; P < 0.05; paired Student’s t-test).
We then performed occlusion experiments by recording evoked firing in brain slices perfused with XE991 before and after glycine application. Under these experimental conditions, evoked firing was not significantly increased by GPR158 activation (Fig. 5C, D; number of APs: pre = 8.27 ± 1.9; post = 8.59 ± 1.40; n = 8 cells from 3 mice; P > 0.05; paired Student’s t-test). These findings supported our hypothesis that the increased firing following GPR158 activation relies on downregulation of Kv7/M channels.
We next performed whole-cell patch-clamp recordings in voltage-clamp configuration and compared the magnitude of Kv7/M-current before and after GPR158 activation in MSNs. The Kv7/M currents are slowly activated and deactivated without inactivation. To measure these currents in relative isolation, a holding potential of 0 mV was used. At this potential, Kv7/M current is steadily activated, whereas most other voltage-gated ion channels are largely inactivated, thus eliminating Ca2+ currents, the A-type K+ currents, and delayed rectifier currents [60,61,62,63,64]. Negative-going steps (-10 mV) from a holding potential of 0 mV evoked a slow inward relaxation (Fig. 6A) characteristic of Kv7/M-current deactivation [61]. The voltage dependence of Kv7/M-currents deactivation was assessed by converting the current amplitudes to peak conductances. The peak conductance-voltage relationship for each cell was described by a first-order Boltzmann function with a deactivation midpoint (V1/2) of – 45.6 ± 1.1 mV (Fig. 6E, F; n = 19 from 6 mice). The deactivation kinetics of the Kv7/M-currents were biphasic over a range of potentials (Wang et al. 1998; Shen et al. 2005), which was also the case under our experimental conditions. The deactivation time constants at – 30 mV were 138.2 ± 20 ms and 1372.1 ± 145 ms (Fig. 6G, I). The gating properties of the recorded channels closely resemble those of the Kv7 family [51, 53, 56, 57], and biophysical characterization was further supported by pharmacology. Indeed these outward M-currents were inhibited by XE991, a selective Kv7 channel blocker (Fig. 6; pre = 169.9 ± 37.5.4 pA; post = 65.4 ± 14.2; n = 7 cells from 3 mice; P < 0.05; paired Student’s t-test) [50], indicating that slow decay currents were indeed mediated by Kv7/M channels.
Under these experimental conditions, we found that Kv7/M current amplitudes were significantly reduced by glycine application (Fig. 7A, B; pre = 199.2 ± 18.4 pA; post = 145.9 ± 15.0; n = 20 cells from 7 mice; P < 0.0001; paired Student’s t-test). Of note, when glycine was applied to MSNs that had been incubated with PKI (1 µM for at least 10 min), no changes in Kv7/M current amplitudes were detected (data not shown; pre = 127.6 ± 18.5 pA; post = 151.4 ± 23.7; n = 7 cells from 3 mice; P > 0.05; paired Student’s t-test), indicating that GPR158-induced negative modulation of Kv7/M current, similarly to the positive modulation of evoked firing, requires PKA-signaling.
We also compared the magnitude of Kv7/M current density in control slices and in slices incubated (for 5–10 min) with glycine. We speculated that activation of the GPR158 signaling pathway would result in a decreased Kv7/M current density in glycine-treated slices.
In support of this hypothesis, we found lower Kv7/M-current density in glycine-treated slices (Fig. 7C, E). Currents density recorded at -30 mV was 3.2 ± 0.3 pA/pF in vehicle-treated slices (n = 23 from 8 mice) and 2.3 ± 0.3 pA/pF in glycine-treated slices (n = 17 from 6 mice; P < 0.05; paired Student’s t-test). Collectively, these results suggest that signaling downstream GPR158 activation inhibits Kv7/M-currents in MSNs.
In the NAc, Kv7 channels are mainly composed of KCNQ2 (Kv7.2) subunits [65,66,67]. To examine the functional expression of Kv7.2 subunits in NAc MSNs and CINs we first employed RNAscope combined with IF as for experiments shown in Fig. 2. Brain sections containing the NAc were used for multiplexed RNAscope plus IF using Kv7.2 antibody and mRNA probes for D1R, D2R, and/or for double immunofluorescence Kv7.2 plus ChAT. Consistent with our electrophysiological data, Kv7.2 immunostaining was found in MSNs expressing D1R or D2R and in CINs (Fig. 8). Quantitative analysis showed that Kv7.2 signal was quite similar in all cell populations considered (D1R or D2R MSNs; CINs) (average optic densities: D1 = 9.06 ± 0.94; D2 = 8.56 ± 0.79; one-way ANOVA; F (2,9) = 0.07; P > 0.05; followed by Bonferroni post hoc test) and CINs (average optic density: CINs = 11.95 ± 0.55; one-way ANOVA; F(2,9) = 0.07; P > 0.05; followed by Bonferroni post hoc test) (Fig. 8A, L). We also evaluated Kv7.2 mRNA levels in single MSNs and CINs by using single-cell qRT-ddPCR. In line with smRNA-FISH results, mRNA levels of Kv7.2 were comparable in single MSNs (D1R or D2R MSNs) and CINs (Fig. 8M, N).
We next performed whole-cell patch-clamp recordings in voltage-clamp configuration and compared Kv7/M-currents before and after glycine application in CINs. In agreement with electrophysiological data shown in Fig. 1D, E, Kv7/M-current amplitudes were not significantly affected by glycine application (pre = 128.2 ± 19.3 pA; post = 113.9 ± 15.8; n = 15 cells from 6 mice; P > 0.05; paired Student’s t-test; Fig. 9A, C;) thus indicating that GPR158 signaling is not involved in the modulation of Kv7/M-currents of CINs.
GPR158-dependent modulation of evoked firing and Kv7/M current requires ERK phosphorylation
We then asked how GPR158-PKA signaling decreases Kv7/M-channel in MSNs. It is well known that increased PKA levels in D1-MSNs lead to phosphorylation of ionotropic glutamate receptors (NR2B subunit of NMDAR and GluR1 subunit of AMPAR), DARPP-32, and CREB [48]. More recently, PKA has been shown to phosphorylate many novel substrates including Rasgrp2. Phosphorylation of Rasgrp2 leads to Rap1 activation, followed by recruitment of the (MAPK)1/3 pathway (also known as ERK1/2), which increases the excitability of D1R-MSNs [47]. Interestingly, ERK1/2 directly phosphorylates Kv7.2 at Ser-414 and Ser-476 in vitro, resulting in downregulation of Kv7.2 function [66].
Based on these findings, we tested whether ERK1/2 phosphorylation is required for the GPR158-dependent effect on MSN intrinsic excitability. When the ERK pathway was disrupted by pre-incubation of slices with U0126, a specific MEK1/2 inhibitor [66], modulation of MSN firing and Kv7/M-current by glycine were prevented (number of APs: pre = 5.96 ± 0.63; post = 6.93 ± 1.25; n = 7 cells from 3 mice; P > 0.05; paired Student’s t-test; Fig. 10A, B; Kv7/M-current: pre = 249.3 ± 40.6 pA; post = 224.4 ± 36.4; n = 8 cells from 3 mice; P > 0.05; paired Student’s t-test; Fig. 10C). In addition, slice pre-incubation with FR180204, a specific ERK inhibitor, prevented glycine effects on MSN firing and Kv7/M-current (number of APs: pre = 5.59 ± 0.51; post = 6.43 ± 0.81; n = 10 cells from 4 mice; P > 0.05; paired Student’s t-test; Fig. 10A, B; Kv7/M-current: pre = 206.7 ± 23.9 pA; post = 193.7 ± 19.4; n = 8 cells from 3 mice; P > 0.05; paired Student’s t-test; Fig. 10C). We then examined whether incubation of NAc slices with glycine increases the levels of phosphorylated ERK1/2. Consistent with our hypothesis, ERK1/2 phosphorylation increased when GPR158 was activated in NAc slices by incubation (5–10 min) with glycine (Fig. 10D; n = 3 mice; statistics by ANOVA with Bonferroni post-hoc test; P = 0.013). An increase in ERK1/2 phosphorylation also occurred when NAc slices were incubated with forskolin, a well-known activator of adenylate cyclase/PKA/ERK signaling (5 µM; Fig. 10D, E; n = 3, statistics by ANOVA with Bonferroni post-hoc test; P < 0.05). Since anti-Kv7.2 phospho-Ser-414 and anti-Kv7.2 phospho-Ser476 antibodies are not commercially available we were unable to confirm whether, in our experimental conditions, the GPR158/PKA/ERK signaling cascade indeed leads to increased Kv7.2 phosphorylation at these sites, as for D1R/PKA/ERK-dependent mechanism [66]. However, by immunoprecipitation experiments, we observed a significant increase in total phosphorylation levels of serine residues (pSER) of Kv7.2 protein following NAc slices incubation (5–10 min) with glycine (Supplementary Fig. 4). Taken together, these results suggest that GPR158 activation, in NAc MSNs, leads to Kv7.2 inhibitory modulation via PKA/ERK cascade.
Discussion
The present work demonstrates that glycine-dependent activation of GPR158 increases MSN excitability in the NAc. Our data also indicate that this effect is mediated by downregulation of Kv7.2 channels via PKA/ERK-dependent phosphorylation. Notably this novel modulatory mechanism is absent in NAc CINs, likely because of low GPR158 density. Our conclusions are supported by the following experimental evidence: i) activation of GPR158 by glycine results in increased evoked firing and Kv7/M current down-regulation; (ii) the increased GPR158-induced firing is prevented by pharmacological inhibition of PKA signaling; (iii) pharmacological blockade of Kv7/M currents mimics and occludes the GPR158-induced effect on MSN excitability; (iv) activation of GPR158 by glycine increases phosphorylation levels of both ERK and total serine residues of Kv7.2; and (v) GPR158-induced increased firing and decreased Kv7/M current are abolished by ERK pathway inhibition.
Noteworthy, these glycine’s effects in MSNs have been observed in experimental conditions in which ionotropic GlyRs and synaptic drives have been antagonized by pharmacological blockade. Indeed, most of the experiments were conducted in slices pre-incubated with picrotoxin, strychnine, NBQX, and APV. Since the metabotropic effect of glycine we observed is an excitatory one, contrasting with the largely inhibitory influence of ionotropic GlyR receptors, our findings strongly support the notion that glycinergic transmission in CNS involves interplay between ionotropic and metabotropic systems as for other neurotransmitters.
GPR158 is extensively expressed in CNS, particularly in the striatum and prefrontal cortex [14, 15, 21, 22]. Our use of multiplex RNAscope combined with immunofluorescence and single-cell qRT-ddPCR provided direct evidence of GPR158 expression in the NAc. Furthermore, our data indicate that mRNA and protein levels of GPR158 are comparable in D1R-MSNs and D2R-MSNs (Fig. 2 and Supplementary Fig. 2). Based on these findings and considering that GPR158 stimulation increased the excitability in the majority of recorded MSNs, we speculate that activation of GPR158 enhances the intrinsic excitability of both MSN subtypes.
In our experimental conditions, GPR158 activation failed to significantly affect evoked firing and Kv7/M current in CINs. Our multiplex RNAscope analysis demonstrated significantly lower Gpr158 mRNA and protein expression in CINs compared to MSNs (Fig. 2 and Supplementary Fig. 2). Although we cannot rule out the possibility that GPR158 may activate alternative intracellular signaling cascade in CINs, we speculate that the lack of effect we observed in CINs could be explained by the lower GPR158 expression levels.
In this study, we also show that M-currents in MSNs are downregulated following GPR158 activation. In striatal MSNs, M-currents were primarily attributable to heteromeric Kv7.2/Kv7.3 channels [65,66,67,68]. Our RNAscope and single-cell ddPCr experiments confirmed the expression of the Kv7.2 channel subunit, whose activity is modulated by GPR158 signaling only in MSNs.
Operating at sub- and suprathreshold voltages, Kv7/M channels produce an outward potassium current that lacks inactivation and activates near resting membrane potential with slow gating kinetics [52, 69]. Thus, the outcome of M-current is the control of numerous aspects of neuronal excitability including setting membrane potential [70, 71], and afterhyperpolarization [56, 57, 72], interspike interval [73, 74] and theta resonance [62, 75]. Noteworthy, Kv7.2 channels contribute to AHP and AP duration [56, 57]. Neurons with decreased Kv7.2 channels expression and/or activity would have shorter AHP amplitudes and AP broadening, which are features allowing neurons to have higher AP firing frequency. Consistently, in our study these effects were found in MSNs after GPR158 activation and following pharmacological blockade of Kv7/M currents. Furthermore, our finding that GPR158 activation reduces Kv7/M current in MSNs, together with the evidence that the pharmacological blockade of Kv7/M current occludes the GPR158-induced increase in MSN excitability, strongly supports the conclusion that Kv7.2 channel is a downstream target of GPR158 signaling in NAc MSNs.
The Kv7/M-current is transiently reduced by a variety of neurotransmitters that activate Gq-protein coupled receptors [69, 76]. The stimulation of the M1/M3 muscarinic receptors [61, 77], metabotropic glutamate receptors [78], κ and δ opioid receptors [79], AT1 angiotensin receptors [80], purinergic P2Y receptors [81], 5-HT2 serotonin receptors [82], and other stimuli have all been shown to suppress the Kv7/M-current. Gq/11 coupled receptors result in the hydrolysis of PIP2 into diacylglycerol (DAG) and inositol triphosphate (IP3), leading to the activation of PKC which phosphorylates Kv7.2 subunit. The phosphorylation of Kv7.2 at S541 located at the distal segment of the CaM-binding site induces the dissociation of CaM from the Kv7.2 channel. Calmodulin‐deficient KCNQ2 channel has a lower affinity towards PIP2. Therefore, the impaired ability to interact with PIP2 leads to a collapse of the channel pore [83] and profound suppression of the M‐channel activity [84]. Alongside this well-characterized Gq-protein-dependent mechanism, it has been recently shown that Kv7.2 channels can be phosphorylated by PKA/Rap1/ERK pathway [47, 66]. Dopamine increases D1R-expressing MSN excitability and firing rates in NAc via the PKA/Rap1/ERK pathway to promote reward behavior [47]. Furthermore, the D1R agonist inhibited Kv7.2-dependent current and increased D1R-MSN firing rates in the NAc slices, and these effects were abolished by ERK inhibition. Notably, decreased Kv7.2 channel activity was mediated by ERK phosphorylation of Kv7.2 at Ser-414 and Ser-476 downstream of the dopamine/PKA/Rap1 pathway [66].
In line with the above evidence, we found that activation of GPR158 signaling by glycine increased ERK phosphorylation. Moreover, GPR158-induced increased firing and decreased Kv7-currents were abolished in MSNs by ERK inhibition. The anti-Kv7.2 phospho-Ser-414 and anti-Kv7.2 phospho-Ser-476 antibodies are not commercially available and, therefore, it remains to be verified whether activation of GPR158 signaling results in increased Kv7.2 channel phosphorylation levels at these inhibitory phosphorylation sites.
It has been shown that GPR158 regulates the intrinsic excitability of pyramidal cells in superficial layers (L2/3) of the medium prefrontal cortex (mPFC) (Song et al. 2019). This effect was not observed in L5 neurons, and it is mediated by Kv4.2 channel modulation via a cAMP-dependent mechanism. Although GPR158 likely regulates several effectors, our observations suggest that its effect on NAc MSN excitability is mainly mediated by Kv7 channels, which are well known for their role in regulating neuronal excitability (Brown & Passmore 2009).
Our findings led us to propose a mechanism via which glycine regulates neuronal excitability as follows: when glycine acts on MSNs, the PKA pathway is activated to induce Kv7.2 phosphorylation via ERK. Phosphorylation of Kv7.2 decreases the channel activity, which in turn increases cell excitability. Alongside increased excitability induced by changes in AP properties (i.e., AHP, AP half-width), the GPR158/PKA/ERK-dependent modulation of Kv7.2 may affect the transition and duration of up-states in vivo. In the NAc, MSNs exhibit up- and down-states in which the membrane potential oscillates between approximately − 85 and − 65 mV [85] in response to cortical and thalamic glutamatergic synaptic activity. The up-state event is critical to striatal signaling because MSNs generate APs only during up-states. These up-state transitions are of variable duration, sometimes lasting seconds [85, 86]. Previous work has revealed that K+ channels are critical determinants of the up-state membrane potential [85]. Kv7.2 channels are suitable for this role because of their ability to open and remain active within the membrane potential range of the upstate. Therefore, negative modulation of Kv7.2 channels by GPR158 activation would increase the responsiveness of MSNs to excitatory cortical and thalamic synaptic inputs. Conversely, decreased activation of GPR158 would reduce the excitability of MSNs during up-states.
In which physiological conditions endogenous glycine may modulate MSN excitability through GPR158 activation? In the adult CNS, glycinergic neurotransmission is most abundant in the spinal cord and brainstem where glycinergic synapses have a well-established role in the control of locomotion and pain processing [2, 87, 88]. Glycinergic innervation is also present in the cerebellum and at low levels in specific regions of the forebrain, where glycine contributes to neuronal inhibition in combination with GABA to maintain the balance between excitation and inhibition [87]. Interestingly, in different brain areas neurons express functional glycine receptors and transporters without the apposition of glycinergic fiber terminals [2, 87]. Therefore, a model emerges by which GPR158 operates through glycine volume transmission. Volume transmission in the brain refers to actions of neuroactive molecules at a distance well beyond the site of release from synapses or cells [89, 90]. Volume transmission offers a communication modality that is more suitable to modulatory and tuning functions because of its slower transmission speed and broader anatomical reach, in comparison to synaptic (wired) transmission, which is specialized for accurate and fast communication. MSN excitability would be modulated by the level of tonic GPR158 activity, which would be determined by the levels of glycine in the extracellular environment. With their ability to control the local glycine availability through glycine transporters [91], astrocytes are ideally positioned to tune GPR158 function. In GPR158-expressing regions with dense glycinergic innervation, such as the brainstem and spinal cord [87, 92], an alternative scenario is conceivable whereby GPR158 operates in a phasic manner by responding to fast synaptic glycine transients. Further studies are required to assess whether GPR158 operates under both a phasic and tonic regime in different brain regions.
Regarding the potential implications of our findings within the context of the pathophysiological role of GPR158 and the glycinergic system in the CNS, it is noteworthy that GPR158 has been demonstrated to be implicated in the etiology of affective disorders, such as cognitive disease and memory loss [12,13,14]. Interestingly, GPR158 has also been identified as a key mediator of stress-induced depression both in mouse models and in humans [13, 14, 18]. A global ablation of GPR158 led to an anti-depressive phenotype in mice, characterized by a lower susceptibility to learned helplessness and reduced anhedonia [13, 14]. Notably, such behavior was rescued by the viral overexpression of GPR158 in the mPFC [14]. Moreover, in multiple behavioral paradigms including the sucrose preference test for anhedonia, GPR158 KO mice showed resilience to chronic stress-induced depression [14]. Since the NAc is a pivotal node in the limbic basal ganglia loop, and its dysfunction results in psychiatric diseases including stress-related disorders such as depression and anxiety (Francis & Lobo, 2017; Gunaydin & Kreitzer, 2016), it is tempting to speculate that Glycine/GPR158-dependent enhancement of MSN excitability we observed could conceivably represent a mechanism by which elevated extracellular glycine levels may promote stress-dependent decisional strategies. Therefore, our findings encourage further studies aimed at elucidating the role of NAc glycine and GPR158 in stress-associated physiological states.
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Lynch JW (2004) Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84:1051–1095. https://doi.org/10.1152/physrev.00042.2003
Legendre P (2001) The glycinergic inhibitory synapse. Cell Mol Life Sci 58:760–793. https://doi.org/10.1007/pl00000899
van den Pol AN, Gorcs T (1988) Glycine and glycine receptor immunoreactivity in brain and spinal cord. J Neurosci 8:472–492. https://doi.org/10.1523/JNEUROSCI.08-02-00472.1988
Husson Z, Rousseau CV, Broll I, Zeilhofer HU, Dieudonne S (2014) Differential GABAergic and glycinergic inputs of inhibitory interneurons and Purkinje cells to principal cells of the cerebellar nuclei. J Neurosci 34:9418–9431. https://doi.org/10.1523/JNEUROSCI.0401-14.2014
Sherman D, Worrell JW, Cui Y, Feldman JL (2015) Optogenetic perturbation of preBotzinger complex inhibitory neurons modulates respiratory pattern. Nat Neurosci 18:408–414. https://doi.org/10.1038/nn.3938
Punnakkal P, von Schoultz C, Haenraets K, Wildner H, Zeilhofer HU (2014) Morphological, biophysical and synaptic properties of glutamatergic neurons of the mouse spinal dorsal horn. J Physiol 592:759–776. https://doi.org/10.1113/jphysiol.2013.264937
Wilcox KS, Fitzsimonds RM, Johnson B, Dichter MA (1996) Glycine regulation of synaptic NMDA receptors in hippocampal neurons. J Neurophysiol 76:3415–3424. https://doi.org/10.1152/jn.1996.76.5.3415
Laboute T, Zucca S, Holcomb M, Patil DN, Garza C, Wheatley BA, Roy RN, Forli S, Martemyanov KA (2023) Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. Science 379:1352–1358. https://doi.org/10.1126/science.add7150
Hou M, Duan L, Slaughter MM (2008) Synaptic inhibition by glycine acting at a metabotropic receptor in tiger salamander retina. J Physiol 586:2913–2926. https://doi.org/10.1113/jphysiol.2008.153437
Li W, Zuo W, Wu W, Zuo QK, Fu R, Wu L, Zhang H, Ndukwe M, Ye JH (2019) Activation of glycine receptors in the lateral habenula rescues anxiety- and depression-like behaviors associated with alcohol withdrawal and reduces alcohol intake in rats. Neuropharmacology 157:107688. https://doi.org/10.1016/j.neuropharm.2019.107688
Fu X, Wei S, Wang T, Fan H, Zhang Y, Costa CD, Brandner S, Yang G, Pan Y, He Y, Li N (2022) Research Status of the Orphan G protein coupled receptor 158 and future perspectives. Cells 11. https://doi.org/10.3390/cells11081334
Kosmidis S, Polyzos A, Harvey L, Youssef M, Denny CA, Dranovsky A, Kandel ER (2018) RbAp48 protein is a critical component of GPR158/OCN signaling and ameliorates age-related memory loss. Cell Rep 25:959–973e6. https://doi.org/10.1016/j.celrep.2018.09.077
Orlandi C, Sutton LP, Muntean BS, Song C, Martemyanov KA (2019) Homeostatic cAMP regulation by the RGS7 complex controls depression-related behaviors. Neuropsychopharmacology 44:642–653. https://doi.org/10.1038/s41386-018-0238-y
Sutton LP, Orlandi C, Song C, Oh WC, Muntean BS, Xie K, Filippini A, Xie X, Satterfield R, Yaeger JDW, Renner KJ, Young SM Jr., Xu B, Kwon H, Martemyanov KA (2018) Orphan receptor GPR158 controls stress-induced depression. Elife 7. https://doi.org/10.7554/eLife.33273
Orlandi C, Posokhova E, Masuho I, Ray TA, Hasan N, Gregg RG, Martemyanov KA (2012) GPR158/179 regulate G protein signaling by controlling localization and activity of the RGS7 complexes. J Cell Biol 197:711–719. https://doi.org/10.1083/jcb.201202123
Orlandi C, Xie K, Masuho I, Fajardo-Serrano A, Lujan R, Martemyanov KA (2015) Orphan receptor GPR158 is an allosteric modulator of RGS7 Catalytic Activity with an essential role in Dictating its expression and localization in the brain. J Biol Chem 290:13622–13639. https://doi.org/10.1074/jbc.M115.645374
Hajj M, De Vita T, Vol C, Renassia C, Bologna JC, Brabet I, Cazade M, Pastore M, Blahos J, Labesse G, Pin JP, Prezeau L (2019) Nonclassical ligand-independent regulation of Go protein by an Orphan Class C G-Protein-coupled receptor. Mol Pharmacol 96:233–246. https://doi.org/10.1124/mol.118.113019
Song C, Orlandi C, Sutton LP, Martemyanov KA (2019) The signaling proteins GPR158 and RGS7 modulate excitability of L2/3 pyramidal neurons and control A-type potassium channel in the prelimbic cortex. J Biol Chem 294:13145–13157. https://doi.org/10.1074/jbc.RA119.007533
Cetereisi D, Kramvis I, Gebuis T, van der Loo RJ, Gouwenberg Y, Mansvelder HD, Li KW, Smit AB, Spijker S (2019) Gpr158 Deficiency impacts hippocampal CA1 neuronal excitability, Dendritic Architecture, and affects spatial learning. Front Cell Neurosci 13:465. https://doi.org/10.3389/fncel.2019.00465
Condomitti G, Wierda KD, Schroeder A, Rubio SE, Vennekens KM, Orlandi C, Martemyanov KA, Gounko NV, Savas JN, de Wit J (2018) An input-specific orphan receptor GPR158-HSPG Interaction organizes hippocampal mossy Fiber-CA3 synapses. Neuron 100:201–215e9. https://doi.org/10.1016/j.neuron.2018.08.038
Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T, Saudou F, Gao XB, Oury F, Kandel E, Karsenty G (2017) Gpr158 mediates osteocalcin’s regulation of cognition. J Exp Med 214:2859–2873. https://doi.org/10.1084/jem.20171320
Chang J, Song Z, Wei S, Zhou Y, Ju J, Yao P, Jiang Y, Jin H, Chi X, Li N (2023) Expression mapping and functional analysis of Orphan G-Protein-coupled receptor GPR158 in the adult mouse brain using a GPR158 transgenic mouse. Biomolecules 13. https://doi.org/10.3390/biom13030479
Groenewegen HJ, Wright CI, Beijer AV, Voorn P (1999) Convergence and segregation of ventral striatal inputs and outputs. Ann N Y Acad Sci 877:49–63. https://doi.org/10.1111/j.1749-6632.1999.tb09260.x
Scofield MD, Heinsbroek JA, Gipson CD, Kupchik YM, Spencer S, Smith AC, Roberts-Wolfe D, Kalivas PW (2016) The Nucleus Accumbens: mechanisms of addiction across drug classes reflect the importance of Glutamate Homeostasis. Pharmacol Rev 68:816–871. https://doi.org/10.1124/pr.116.012484
Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr., Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429–1432. https://doi.org/10.1126/science.2147780
Kupchik YM, Brown RM, Heinsbroek JA, Lobo MK, Schwartz DJ, Kalivas PW (2015) Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections. Nat Neurosci 18:1230–1232. https://doi.org/10.1038/nn.4068
Smith RJ, Lobo MK, Spencer S, Kalivas PW (2013) Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). Curr Opin Neurobiol 23:546–552. https://doi.org/10.1016/j.conb.2013.01.026
Zhou FM, Wilson CJ, Dani JA (2002) Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 53:590–605. https://doi.org/10.1002/neu.10150
Williams MJ, Adinoff B (2008) The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33:1779–1797. https://doi.org/10.1038/sj.npp.1301585
Mark GP, Shabani S, Dobbs LK, Hansen ST (2011) Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 104:76–81. https://doi.org/10.1016/j.physbeh.2011.04.052
Aceto G, Re A, Mattera A, Leone L, Colussi C, Rinaudo M, Scala F, Gironi K, Barbati SA, Fusco S, Green T, Laezza F, D’Ascenzo M, Grassi C (2019) GSK3β modulates timing-dependent long-term depression through direct phosphorylation of Kv4.2 channels. Cereb Cortex 29:1851–1865. https://doi.org/10.1093/cercor/bhy042
Aceto G, Nardella L, Lazzarino G, Tavazzi B, Bertozzi A, Nanni S, Colussi C, D’Ascenzo M, Grassi C (2022) Acute restraint stress impairs histamine type 2 receptor ability to increase the excitability of medium spiny neurons in the nucleus accumbens. Neurobiol Dis 175:105932. https://doi.org/10.1016/j.nbd.2022.105932
D’Ascenzo M, Podda MV, Fellin T, Azzena GB, Haydon P, Grassi C (2009) Activation of mGluR5 induces spike afterdepolarization and enhanced excitability in medium spiny neurons of the nucleus accumbens by modulating persistent na + currents. J Physiol 587:3233–3250. https://doi.org/10.1113/jphysiol.2009.172593
Bennett BD, Callaway JC, Wilson CJ (2000) Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J Neurosci 20:8493–8503. https://doi.org/10.1523/JNEUROSCI.20-22-08493.2000
Meitzen J, Weaver AL, Brenowitz EA, Perkel DJ (2009) Plastic and stable electrophysiological properties of adult avian forebrain song-control neurons across changing breeding conditions. J Neurosci 29:6558–6567. https://doi.org/10.1523/JNEUROSCI.5571-08.2009
Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo HT, Ma XJ, Luo Y (2012) RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14:22–29. https://doi.org/10.1016/j.jmoldx.2011.08.002
Aceto G, Nardella L, Lazzarino G, Tavazzi B, Bertozzi A, Nanni S, Colussi C, D’Ascenzo M, Grassi C (2022) Acute restraint stress impairs histamine type 2 receptor ability to increase the excitability of medium spiny neurons in the nucleus accumbens. Neurobiol Dis 175. https://doi.org/10.1016/j.nbd.2022.105932
Aceto G, Nardella L, Nanni S, Pecci V, Bertozzi A, Colussi C, D’Ascenzo M, Grassi C (2022) Activation of histamine type 2 receptors enhances intrinsic excitability of medium spiny neurons in the nucleus accumbens. J Physiol 600:2225–2243. https://doi.org/10.1113/JP282962
Cadwell CR, Scala F, Li S, Livrizzi G, Shen S, Sandberg R, Jiang X, Tolias AS (2017) Multimodal profiling of single-cell morphology, electrophysiology, and gene expression using Patch-Seq. Nat Protoc 12:2531–2553. https://doi.org/10.1038/nprot.2017.120
Possieri C, Locantore P, Salis C, Bacci L, Aiello A, Fadda G, De Crea C, Raffaelli M, Bellantone R, Grassi C, Strigari L, Farsetti A, Pontecorvi A, Nanni S (2021) Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer. Endocrine 72:711–720. https://doi.org/10.1007/s12020-020-02508-w
Hopf FW, Cascini MG, Gordon AS, Diamond I, Bonci A (2003) Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci 23:5079–5087
Dong Y, Green T, Saal D, Marie H, Neve R, Nestler EJ, Malenka RC (2006) CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci 9:475–477. https://doi.org/10.1038/nn1661
Kawaguchi Y (1993) Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci 13:4908–4923. https://doi.org/10.1523/JNEUROSCI.13-11-04908.1993
Blomeley C, Bracci E (2005) Excitatory effects of serotonin on rat striatal cholinergic interneurones. J Physiol 569:715–721. https://doi.org/10.1113/jphysiol.2005.098269
Wilson CJ (2005) The mechanism of intrinsic amplification of hyperpolarizations and spontaneous bursting in striatal cholinergic interneurons. Neuron 45:575–585. https://doi.org/10.1016/j.neuron.2004.12.053
Cadwell CR, Palasantza A, Jiang X, Berens P, Deng Q, Yilmaz M, Reimer J, Shen S, Bethge M, Tolias KF, Sandberg R, Tolias AS (2016) Electrophysiological, transcriptomic and morphologic profiling of single neurons using Patch-Seq. Nat Biotechnol 34:199–203. https://doi.org/10.1038/nbt.3445
Nagai T, Nakamuta S, Kuroda K, Nakauchi S, Nishioka T, Takano T, Zhang X, Tsuboi D, Funahashi Y, Nakano T, Yoshimoto J, Kobayashi K, Uchigashima M, Watanabe M, Miura M, Nishi A, Kobayashi K, Yamada K, Amano M, Kaibuchi K (2016) Phosphoproteomics of the dopamine pathway enables Discovery of Rap1 activation as a reward signal in vivo. Neuron 89:550–565. https://doi.org/10.1016/j.neuron.2015.12.019
Nagai T, Yoshimoto J, Kannon T, Kuroda K, Kaibuchi K (2016) Phosphorylation signals in Striatal medium spiny neurons. Trends Pharmacol Sci 37:858–871. https://doi.org/10.1016/j.tips.2016.07.003
Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182–217. https://doi.org/10.1124/pr.110.002642
Brown DA, Passmore GM (2009) Neural KCNQ (Kv7) channels. Br J Pharmacol 156:1185–1195. https://doi.org/10.1111/j.1476-5381.2009.00111.x
Jentsch TJ (2000) Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 1:21–30. https://doi.org/10.1038/35036198
Robbins J (2001) KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 90:1–19. https://doi.org/10.1016/s0163-7258(01)00116-4
Delmas P, Brown DA (2005) Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 6:850–862. https://doi.org/10.1038/nrn1785
Bal M, Zhang J, Zaika O, Hernandez CC, Shapiro MS (2008) Homomeric and heteromeric assembly of KCNQ (Kv7) K + channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis. J Biol Chem 283:30668–30676. https://doi.org/10.1074/jbc.M805216200
Bai S, Guo W, Feng Y, Deng H, Li G, Nie H, Guo G, Yu H, Ma Y, Wang J, Chen S, Jing J, Yang J, Tang Y, Tang Z (2020) Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry 91:21–32. https://doi.org/10.1136/jnnp-2019-320912
Simkin D, Marshall KA, Vanoye CG, Desai RR, Bustos BI, Piyevsky BN, Ortega JA, Forrest M, Robertson GL, Penzes P, Laux LC, Lubbe SJ, Millichap JJ, George AL Jr., Kiskinis E (2021) Dyshomeostatic modulation of Ca(2+)-activated K(+) channels in a human neuronal model of KCNQ2 encephalopathy. Elife 10. https://doi.org/10.7554/eLife.64434
Tzingounis AV, Nicoll RA (2008) Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. Proc Natl Acad Sci U S A 105:19974–19979. https://doi.org/10.1073/pnas.0810535105
Guan D, Higgs MH, Horton LR, Spain WJ, Foehring RC (2011) Contributions of Kv7-mediated potassium current to sub- and suprathreshold responses of rat layer II/III neocortical pyramidal neurons. J Neurophysiol 106:1722–1733. https://doi.org/10.1152/jn.00211.2011
Battefeld A, Tran BT, Gavrilis J, Cooper EC, Kole MH (2014) Heteromeric Kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons. J Neurosci 34:3719–3732. https://doi.org/10.1523/JNEUROSCI.4206-13.2014
Brown DA, Adams PR (1980) Muscarinic suppression of a novel voltage-sensitive K + current in a vertebrate neurone. Nature 283:673–676. https://doi.org/10.1038/283673a0
Halliwell JV, Adams PR (1982) Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res 250:71–92. https://doi.org/10.1016/0006-8993(82)90954-4
Hu H, Vervaeke K, Storm JF (2002) Two forms of electrical resonance at theta frequencies, generated by M-current, h-current and persistent na + current in rat hippocampal pyramidal cells. J Physiol 545:783–805. https://doi.org/10.1113/jphysiol.2002.029249
Storm JF (1990) Potassium currents in hippocampal pyramidal cells. Prog Brain Res 83:161–187. https://doi.org/10.1016/s0079-6123(08)61248-0
Grassi C, D’Ascenzo M, Azzena GB (2004) Modulation of ca(v)1 and ca(v)2.2 channels induced by nitric oxide via cGMP-dependent protein kinase. Neurochem Int 45:885–893. https://doi.org/10.1016/j.neuint.2004.03.019
McGuier NS, Griffin WC 3rd, Gass JT, Padula AE, Chesler EJ, Mulholland PJ (2016) Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption. Addict Biol 21:1097–1112. https://doi.org/10.1111/adb.12279
Tsuboi D, Otsuka T, Shimomura T, Faruk MO, Yamahashi Y, Amano M, Funahashi Y, Kuroda K, Nishioka T, Kobayashi K, Sano H, Nagai T, Yamada K, Tzingounis AV, Nambu A, Kubo Y, Kawaguchi Y, Kaibuchi K (2022) Dopamine drives neuronal excitability via KCNQ channel phosphorylation for reward behavior. Cell Rep 40:111309. https://doi.org/10.1016/j.celrep.2022.111309
Saganich MJ, Machado E, Rudy B (2001) Differential expression of genes encoding subthreshold-operating voltage-gated K + channels in brain. J Neurosci 21:4609–4624. https://doi.org/10.1523/JNEUROSCI.21-13-04609.2001
Shen W, Hamilton SE, Nathanson NM, Surmeier DJ (2005) Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. J Neurosci 25:7449–7458. https://doi.org/10.1523/JNEUROSCI.1381-05.2005
Greene DL, Hoshi N (2017) Modulation of Kv7 channels and excitability in the brain. Cell Mol Life Sci 74:495–508. https://doi.org/10.1007/s00018-016-2359-y
Huang H, Trussell LO (2011) KCNQ5 channels control resting properties and release probability of a synapse. Nat Neurosci 14:840–847. https://doi.org/10.1038/nn.2830
Schwarz JR, Glassmeier G, Cooper EC, Kao TC, Nodera H, Tabuena D, Kaji R, Bostock H (2006) KCNQ channels mediate IKs, a slow K + current regulating excitability in the rat node of Ranvier. J Physiol 573:17–34. https://doi.org/10.1113/jphysiol.2006.106815
Zhang L, McBain CJ (1995) Potassium conductances underlying repolarization and after-hyperpolarization in rat CA1 hippocampal interneurones. J Physiol 488(3):661–672. https://doi.org/10.1113/jphysiol.1995.sp020998
Nigro MJ, Mateos-Aparicio P, Storm JF (2014) Expression and functional roles of Kv7/KCNQ/M-channels in rat medial entorhinal cortex layer II stellate cells. J Neurosci 34:6807–6812. https://doi.org/10.1523/JNEUROSCI.4153-13.2014
Lawrence JJ, Saraga F, Churchill JF, Statland JM, Travis KE, Skinner FK, McBain CJ (2006) Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons. J Neurosci 26:12325–12338. https://doi.org/10.1523/JNEUROSCI.3521-06.2006
Peters HC, Hu H, Pongs O, Storm JF, Isbrandt D (2005) Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 8:51–60. https://doi.org/10.1038/nn1375
Marrion NV (1997) Control of M-current. Annu Rev Physiol 59:483–504. https://doi.org/10.1146/annurev.physiol.59.1.483
Bernheim L, Mathie A, Hille B (1992) Characterization of muscarinic receptor subtypes inhibiting Ca2 + current and M current in rat sympathetic neurons. Proc Natl Acad Sci U S A 89:9544–9548. https://doi.org/10.1073/pnas.89.20.9544
Charpak S, Gahwiler BH, Do KQ, Knopfel T (1990) Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters. Nature 347:765–767. https://doi.org/10.1038/347765a0
Moore SD, Madamba SG, Schweitzer P, Siggins GR (1994) Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J Neurosci 14:809–820. https://doi.org/10.1523/JNEUROSCI.14-02-00809.1994
Shapiro MS, Wollmuth LP, Hille B (1994) Angiotensin II inhibits calcium and M current channels in rat sympathetic neurons via G proteins. Neuron 12:1319–1329. https://doi.org/10.1016/0896-6273(94)90447-2
Adams PR, Brown DA, Constanti A (1982) Pharmacological inhibition of the M-current. J Physiol 332:223–262. https://doi.org/10.1113/jphysiol.1982.sp014411
Colino A, Halliwell JV (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328:73–77. https://doi.org/10.1038/328073a0
Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K + channel Kir2.2. Nature 477:495–498. https://doi.org/10.1038/nature10370
Kosenko A, Kang S, Smith IM, Greene DL, Langeberg LK, Scott JD, Hoshi N (2012) Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation. EMBO J 31:3147–3156. https://doi.org/10.1038/emboj.2012.156
Wilson CJ, Kawaguchi Y (1996) The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci 16:2397–2410. https://doi.org/10.1523/JNEUROSCI.16-07-02397.1996
Wickens JR, Wilson CJ (1998) Regulation of action-potential firing in spiny neurons of the rat neostriatum in vivo. J Neurophysiol 79:2358–2364. https://doi.org/10.1152/jn.1998.79.5.2358
Zeilhofer HU, Studler B, Arabadzisz D, Schweizer C, Ahmadi S, Layh B, Bosl MR, Fritschy JM (2005) Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. J Comp Neurol 482:123–141. https://doi.org/10.1002/cne.20349
Zeilhofer HU, Acuna MA, Gingras J, Yevenes GE (2018) Glycine receptors and glycine transporters: targets for novel analgesics? Cell Mol Life Sci 75:447–465. https://doi.org/10.1007/s00018-017-2622-x
Agnati LF, Guidolin D, Guescini M, Genedani S, Fuxe K (2010) Understanding wiring and volume transmission. Brain Res Rev 64:137–159. https://doi.org/10.1016/j.brainresrev.2010.03.003
Taber KH, Hurley RA (2014) Volume transmission in the brain: beyond the synapse. J Neuropsychiatry Clin Neurosci 26(iv):1–4. https://doi.org/10.1176/appi.neuropsych.13110351
Harvey RJ, Yee BK (2013) Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov 12:866–885. https://doi.org/10.1038/nrd3893
Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, Sevarino KA (1995) Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15:6498–6508. https://doi.org/10.1523/JNEUROSCI.15-10-06498.1995
Acknowledgements
We would like to acknowledge the contribution of “Electrophysiology” and “Microscopy” Core Facilities G-STeP, Fondazione Policlinico Universitario “A. Gemelli” IRCCS.
Funding
Open access funding provided by Università Cattolica del Sacro Cuore within the CRUI-CARE Agreement. This work was supported by the Italian Ministry of University and Research (PRIN 2022-Prot. 2022YEPFB7 to MD; PRIN 2022 PNRR Prot. P20222WFZ3 to MD) and “Ricerca Corrente” from Fondazione Policlinico Universitario “A. Gemelli” IRCCS to C.G.
Author information
Authors and Affiliations
Contributions
GA and LN performed and analyzed electrophysiological experiments; CC, AB and LN performed Western blot experiments; VP, GA and SN performed high-quality single cell RNA analysis by droplet digital PCR. MTV and SN performed RNAscope and immunofluorescence experiments; MD and CG conceived the study supervised the work; MD wrote the paper. All authors gave approval to the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
All experiments were carried out in accordance with the guidelines established by the European Communities Council (Directive 2010/63/EU of March 4th, 2014) and were approved by the Italian Ministry of Health (authorization n° 623/2022-PR).
Consent to participate
NA. The study does not involve any human subjects.
Consent for publication
NA. The manuscript does not contain any individual person’s data.
Conflict of interest
All authors declare that the research was conducted in the absence of any commercial and financial relationships that could be construed as a potential conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Aceto, G., Nardella, L., Nanni, S. et al. Glycine-induced activation of GPR158 increases the intrinsic excitability of medium spiny neurons in the nucleus accumbens. Cell. Mol. Life Sci. 81, 268 (2024). https://doi.org/10.1007/s00018-024-05260-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-024-05260-w